We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Vascular Protein Receptor May Protect Against Cardiovascular Disease

By LabMedica International staff writers
Posted on 20 Mar 2012
The protein called pregnane X receptor (PXR) has been found to be active in vascular tissue where it upregulates drug metabolism, transport, and antioxidant genes to protect the vasculature from both endogenous and exogenous damage.

PXR is a nuclear receptor whose primary function is to sense the presence of foreign toxic substances and in response upregulate the expression of proteins involved in the detoxification and clearance of these substances from the body. PXR belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain.

In a study published in the March 15, 2012, issue of the journal Cardiovascular Research, a team of British investigators reported that they had detected PXR in primary human and rat aortic endothelial and smooth muscle cells and in blood vessels including the human and rat aorta. Activation of aortic PXR by classical agonists had several protective effects: increased xenobiotic metabolism demonstrated by bioactivation of the pro-drug clopidogrel, which reduced adenosine diphosphate-induced platelet aggregation; increased expression of multidrug resistance protein 1, mediating chemical efflux from the vasculature; and protection from reactive oxygen species-mediated cell death.

“We have known for a long time that this protein has an important role sorting out waste products in the liver--now we believe it could have an important role in protecting the body against cardiovascular disease,” said senior author Dr. David Bishop-Bailey, lecturer on cardiovascular and inflammatory disorders at the William Harvey Research Institute (London, United Kingdom). “Since blood travels everywhere in the body, PXR has the potential to provide protection not just through its actions in the liver, but anywhere in the entire body. If we can work out how to manipulate PXR to turn on detoxification and antioxidant pathways in blood vessels, we may be a step closer to preventing our nation's biggest killer.”

Related Links:
William Harvey Research Institute


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Urinalysis Solution
UN-9000

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
20 Mar 2012  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
20 Mar 2012  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
20 Mar 2012  |   BioResearch